You're signed outSign in or to get full access.
Catalio Capital Management, LP
Catalio Capital Management, LP is a New York-based investment firm founded in 2020. The firm specializes in the full lifecycle of innovative healthcare investing across private, public, and credit markets, supporting category-defining businesses in life sciences and biotechnology. Catalio is led by a team of managing partners, associates, and a board of advisors, with a network of renowned scientist-entrepreneurs as Venture Partners. The firm employs approximately 36 professionals and manages more than $1.7 billion in assets for institutional and sophisticated investors.
Investment Strategy
Catalio Capital Management invests in innovative healthcare companies at all stages and across the capital structure, including private equity, structured opportunities, and public equities. The firm leverages a proprietary network of scientist-entrepreneurs for rigorous scientific due diligence and aims to advise on disruptive trends in life sciences by providing early exposure to biomedical technologies. Catalio's investment approach is driven by deep scientific insight, a focus on emerging healthcare innovations, and the ability to generate value throughout companies' life cycles.
Latest 13F Filing Activity
Catalio Capital Management, LP filed their most recent 13F report on Jun 30, 2025 disclosing 39 equity positions with a total 13F market value of $477M. The fund increased holdings in Gilead Sciences Inc., Boston Scientific Corp., Soleno Therapeutics Inc. among other positions. Catalio Capital Management, LP reduced exposure to Becton Dickinson & Co., Springworks Therapeutics Inc., Veracyte Inc. among others.
Top Holdings
Equity Positions (39)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
L LLY | ELI LILLY & CO | 8.81% | $42.0M | 53,916 | $799.90 | $779.53 | +$22.5M |
B BBIO | BRIDGEBIO PHARMA INC | 8.40% | $40.1M | 927,711 | $27.92 | $43.18 | +$6.8M |
S SLNO | SOLENO THERAPEUTICS INC | 7.20% | $34.3M | 409,944 | $78.94 | $83.78 | +$22.8M |
A ASND | ASCENDIS PHARMA A/S | 6.51% | $31.1M | 179,926 | $137.67 | $172.60 | +$581.0K |
I ISRG | INTUITIVE SURGICAL INC | 6.46% | $30.8M | 56,674 | $529.60 | $543.41 | +$12.7M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more